Clostridia difficile infection (CDI) is epidemic in the United States with more than 300,000 new cases per year and 25,000 deaths per year. Although treatable with antibiotics, recurrent CDI is debilitating, costly and lethal. Recurrent CDI often does not resolve with antibiotic use, prompting unconventional measures such as stool transplantation or fecal microbiota transplantation [...]
How do you choose a gastroenterologist for your screening colonoscopy? Everyone wants “a good doctor” but how do you evaluate your gastroenterologist? If a gastroenterologist is diligent, thorough and spends adequate time during a colonoscopy, polyp detection improves. Polyp detection is key since the removal of adenomatous (precancerous) polyps has been shown in tightly [...]
Proton pump inhibitors (PPI) such as Prilosec, Nexium, Prevacid, Dexilant, and Aciphex have recently been associated with cognitive decline or dementia. In a study published this month in Gastroenterology, 10,486 volunteers within the NIH-supported Alzheimer’s Disease Centers who were aged 50 years and older and had either normal cognition or mild cognitive impairment at [...]
In a retrospective study published in Clinical Gastroenterology and Hepatology researchers report “that in states that legalized marijuana for medical purposes, chronic use of cannabinoid derivatives has led to a significant increase in cannabinoid hyperemesis syndrome, characterized by episodes of severe nausea and cyclical vomiting.”
A recently published study of claims data from a German health plan suggests an association between proton pump inhibitor (PPI) use and dementia in the elderly. Because the claims data used in the current study lack detailed sociodemographic data, such as diet, lifestyle and education, the researchers could not integrate these important factors into the [...]
Gastroenterology Group of Naples Welcomes New Female Physician NAPLES, FL (Jan. 4, 2016) – Gastroenterology Group of Naples is pleased to announce the addition of Sandra M. Jara, M.D. Dr. Jara is board-certified in gastroenterology and will provide skilled endoscopy, colonoscopy, and small bowel capsule services. She will be accepting new patients starting January [...]
FDA Approves New Hepatitis C Drug January 29, 2016The Food and Drug Administration (FDA) has approved Merck & Co.’s Zepatier (elbasvir and grazoprevir), a once-daily, single-tablet combination therapy for hepatitis C. The drug is approved for patients with the most common type of hepatitis C in the US, genotype 1, as well as genotype 4. [...]